Live feed
Filing
SC 13G/A
SC 13G/A0000950170-23-002427·Prelude Therapeutics Inc
Schedule 13G ownership disclosure
Prelude Therapeutics, Inc.
Security class unavailable · CUSIP: 74065P101
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,299,323
- Percent of class
- 11.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-23-002427
- Form type
- SC 13G/A
- Filer
- Prelude Therapeutics Inc
- CIK
- CIK 1678660
- Filed
- Feb 10, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership